4D Molecular Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 04 Jan 24 | SellUS$10,546,200 | Viking Global Investors LP | Company | 540,000 | US$19.53 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 1,816,315 | 3.33% |
| VC/PE Firms | 13,594,663 | 24.9% |
| Institutions | 39,090,574 | 71.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.1%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 5,098,211 | US$39.7m | 0% | 0.51% | |||
| 4,868,789 | US$37.9m | -0.57% | no data | |||
| 4,400,000 | US$34.3m | 0% | 1.69% | |||
| 4,096,452 | US$31.9m | 0.86% | 1.03% | |||
| 3,231,452 | US$25.2m | -20.6% | 0.01% | |||
| 3,137,087 | US$24.4m | -1.87% | 0.01% | |||
| 2,767,717 | US$21.6m | 9.47% | no data | |||
| 2,116,508 | US$16.5m | 1.79% | no data | |||
| 1,702,642 | US$13.3m | -76.9% | 0.41% | |||
| 1,668,986 | US$13.0m | 17.1% | no data | |||
| 1,659,153 | US$12.9m | 0% | no data | |||
| 1,543,414 | US$12.0m | 238% | 0.02% | |||
| 1,500,000 | US$11.7m | 7.14% | 0.01% | |||
| 1,262,090 | US$9.8m | 17.6% | 0.56% | |||
| 1,225,448 | US$9.5m | 232% | 0.43% | |||
| 1,150,000 | US$9.0m | 43.8% | 0.6% | |||
| 1,036,545 | US$8.1m | -2.29% | no data | |||
| 838,492 | US$6.5m | -51.9% | 0.03% | |||
| 803,490 | US$6.3m | -5.49% | 0.08% | |||
| 802,637 | US$6.3m | 546% | no data | |||
| 462,911 | US$3.6m | 0% | 0.71% | |||
| 459,000 | US$3.6m | -35% | 0.01% | |||
| 430,683 | US$3.4m | 17.2% | no data | |||
| 422,856 | US$3.3m | -52% | 0.06% | |||
| 397,835 | US$3.1m | 14.4% | 0.71% |